EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis

Benedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David Josef Maria Bauer, Lorenz Balcar, Rafael Paternostro, Philipp Schwabl, Georg Semmler, Bernhard Scheiner, Albert Friedrich Staettermayer, Michael Trauner und 2 weitere

Clinical Gastroenterology and Hepatology · 2023-08 · 21 (9) · 2308-2317.e7

DOI: 10.1016/j.cgh.2022.11.033 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-08. Verfasst von Benedikt Silvester Hofer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic La…. Hauptthemen laut MEDLINE: Hypertension, Portal, Liver Cirrhosis. Die Arbeit wurde bisher 135-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Alcohol-related liver disease is a leading cause of liver-related mortality. The effect of alcohol abstinence on the natural history of alcohol-related cirrhosis across distinct stages of portal hypertension has not been thoroughly investigated. In this study, we assessed the clinical implications of abstinence in patients with alcohol-related cirrhosis and clinically significant portal hypertension. METHODS: Alcohol abstinence, hepatic decompensation, and mortality were assessed in patients with alcohol-related cirrhosis who underwent a baseline hepatic venous pressure gradient (HVPG) measurement and were diagnosed with clinically significant portal hypertension (HVPG ≥10 mm Hg). RESULTS: A total of 320 patients with alcohol-related cirrhosis (median age: 57 [interquartile range (IQR), 49.7-63.1] years; 75.6% male; 87.5% decompensated) and a median HVPG of 20 (IQR, 17-23) mm Hg were followed up for a median of 36 (IQR, 14-80) months. Overall, 241 (75.3%) patients remained abstinent, while 79 (24.7%) patients had active alcohol consumption. Alcohol abstinence was linked to a significantly reduced risk of hepatic decompensation (adjusted hazard ratio [aHR], 0.391; P < .001), as well as liver-related (aHR, 0.428; P < .001) and all-cause (aHR, 0.453; P < .001) mortality, after adjusting for baseline HVPG, MELD, and previous decompensation. Importantly, alcohol abstinence significantly reduced the cumulative incidence of hepatic decompensation in both groups with HVPG 10-19 mm Hg (P < .001) and HVPG ≥20 mm Hg (P = .002). The 3-year decompensation probability was 32.4% vs 60.0% in HVPG 10-19 mm Hg and 57.5% vs 82.6% in HVPG ≥20 mm Hg for abstinent patients vs active drinkers, respectively. CONCLUSIONS: Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis, including in patients who have already progressed to high-risk portal hypertension. (ClinicalTrials.gov, Number: NCT03267615).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PortalLiver CirrhosisFemaleHumansMaleMiddle AgedAlcohol AbstinenceLiver Cirrhosis, AlcoholicPrognosis

Stichwörter der Autor:innen

Advanced Chronic Liver DiseaseAlcohol-Related Liver DiseaseHepatic DecompensationHepatic Venous Pressure GradientLiver-Related Mortality

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine…
  • Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Zitieren

APA

Hofer, B. S., Simbrunner, B., Hartl, L., Jachs, M., Bauer, D. J. M., Balcar, L., Paternostro, R., Schwabl, P., Semmler, G., Scheiner, B., Staettermayer, A. F., Trauner, M., Mandorfer, M., & Reiberger, T. (2023). Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis. Clinical Gastroenterology and Hepatology, 21(9), 2308-2317.e7. https://doi.org/10.1016/j.cgh.2022.11.033

Vancouver

Hofer BS, Simbrunner B, Hartl L, Jachs M, Bauer DJM, Balcar L, et al. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis. Clinical Gastroenterology and Hepatology. 2023;21(9):2308-2317.e7. doi:10.1016/j.cgh.2022.11.033

BibTeX
@article{Hofer2023,
  author = {Hofer, Benedikt Silvester and Simbrunner, Benedikt and Hartl, Lukas and Jachs, Mathias and Bauer, David Josef Maria and Balcar, Lorenz and Paternostro, Rafael and Schwabl, Philipp and Semmler, Georg and Scheiner, Bernhard and Staettermayer, Albert Friedrich and Trauner, Michael and Mandorfer, Mattias and Reiberger, Thomas},
  title = {Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {9},
  pages = {2308--2317.e7},
  doi = {10.1016/j.cgh.2022.11.033}
}
Kostenlos starten →